Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors

被引:0
作者
Toth, Paul D. [1 ]
Ratigan, Steven C. [2 ]
Powell, Joshua W. [2 ]
Cassel, Sydney R. [3 ]
Yalowich, Jack C. [3 ]
McElroy, Craig A. [2 ]
Lindert, Steffen [1 ]
Bell, Charles E. [4 ]
Mitton-Fry, Mark J. [2 ]
机构
[1] Ohio State Univ, Coll Arts & Sci, Dept Chem & Biochem, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmacol, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2025年
基金
美国国家卫生研究院;
关键词
gyrase; amide; triazole; crystallography; moleculardynamics; DNA GYRASE; DERIVATIVES; SAR;
D O I
10.1021/acsmedchemlett.5c00060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel bacterial topoisomerase inhibitors (NBTIs) targeting DNA gyrase and topoisomerase IV constitute a new antibacterial class for deadly pathogens such as MRSA. While most NBTIs induce gyrase-mediated single-strand DNA breaks, a subset of amide NBTIs induces both single-strand and double-strand DNA breaks. Here, we report the X-ray crystal structures of two such amide NBTIs, 148 and 185, and demonstrate an unusual binding mode characterized by engagement of both GyrA D83 and R122. The synthesis of two isosteric triazole NBTIs is also described, one of which (342) affords only single-strand DNA breaks, while the other (276) also induces both single- and double-strand DNA breaks. A combination of docking and molecular dynamics simulations is employed to further investigate the potential structural underpinnings of differences in DNA cleavage.
引用
收藏
页码:660 / 667
页数:8
相关论文
共 50 条
  • [31] Identification and mechanistic exploration of structural and conformational dynamics of NF-kB inhibitors: rationale insights from in silico and in vitro studies
    Srivastava, Amit Kumar
    Srivastava, Shubham
    Kumar, Viney
    Ghosh, Souvik
    Yadav, Siddharth
    Malik, Ruchi
    Roy, Partha
    Prasad, Ramasare
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (03) : 1485 - 1505
  • [32] QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors
    Zhu, Lin
    Yu, Yongle
    Ma, Youfu
    Shi, Yenong
    Kowah, Jamal Alzobair Hammad
    Wang, Lisheng
    Yuan, Mingqing
    Liu, Xu
    FITOTERAPIA, 2024, 175
  • [33] Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity
    Surivet, Jean-Philippe
    Zumbrunn, Cornelia
    Rueedi, Georg
    Hubschwerlen, Christian
    Bur, Daniel
    Bruyere, Thierry
    Locher, Hans
    Ritz, Daniel
    Keck, Wolfgang
    Seiler, Peter
    Kohl, Christopher
    Gauvin, Jean-Christophe
    Mirre, Azely
    Kaegi, Verena
    Dos Santos, Marina
    Gaertner, Mika
    Delers, Jonathan
    Enderlin-Paput, Michel
    Boehme, Maria
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7396 - 7415
  • [34] Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
    Reck, Folkert
    Ehmann, David E.
    Dougherty, Thomas J.
    Newmana, Joseph V.
    Hopkins, Sussie
    Stone, Gregory
    Agrawal, Nikunj
    Ciaccio, Paul
    McNulty, John
    Barthlow, Herbert
    O'Donnell, Jennifer
    Goteti, Kosalaram
    Breen, John
    Comita-Prevoir, Janelle
    Cornebise, Mark
    Cronin, Mark
    Eyermann, Charles J.
    Geng, Bolin
    Carr, Greg R.
    Pandarinathan, Lakshmipathi
    Tang, Xuejun
    Cottone, Andrew
    Zhao, Liang
    Bezdenejnih-Snyder, Natascha
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5392 - 5409
  • [35] Structural insights into the committed step of bacterial phospholipid biosynthesis
    Li, Zhenjian
    Tang, Yannan
    Wu, Yiran
    Zhao, Suwen
    Bao, Juan
    Luo, Yitian
    Li, Dianfan
    NATURE COMMUNICATIONS, 2017, 8
  • [36] Design and examination of potent pseudosubstrate-based oligonucleotide inhibitors against bacterial topoisomerase IV
    Li, Tyler
    Guo, Juanjuan
    Zhang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4817 - 4822
  • [37] Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
    Singh, Priti
    Arifuddin, Mohammed
    Supuran, Claudiu T.
    Nerella, Sridhar Goud
    BIOORGANIC CHEMISTRY, 2025, 156
  • [38] Structural insights into the assembly of type IIA topoisomerase DNA cleavage-religation center
    Liu, Ko-Ting
    Chen, Shin-Fu
    Chan, Nei-Li
    NUCLEIC ACIDS RESEARCH, 2024, 52 (16) : 9788 - 9802
  • [39] Structural insights into fungal and human topoisomerase II with implications for in silico antifungal drug design
    Sappati, Subrahmanyam
    Kondaka, Kavya
    Gabriel, Iwona
    Baginski, Maciej
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [40] Structural basis of femtomolar inhibitors for acetylcholinesterase subtype selectivity: Insights from computational simulations
    Zhu, Xiao-Lei
    Yu, Ning-Xi
    Hao, Ge-Fei
    Yang, Wen-Chao
    Yang, Guang-Fu
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 41 : 55 - 60